Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Merit Medical Systems (MMSI) over the last 16 years, with Q3 2025 value amounting to $147.4 million.

  • Merit Medical Systems' Accumulated Expenses rose 1581.23% to $147.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $147.4 million, marking a year-over-year increase of 1581.23%. This contributed to the annual value of $134.1 million for FY2024, which is 1131.62% up from last year.
  • Merit Medical Systems' Accumulated Expenses amounted to $147.4 million in Q3 2025, which was up 1581.23% from $140.2 million recorded in Q2 2025.
  • Merit Medical Systems' 5-year Accumulated Expenses high stood at $159.0 million for Q4 2021, and its period low was $110.7 million during Q2 2023.
  • Moreover, its 5-year median value for Accumulated Expenses was $123.2 million (2022), whereas its average is $127.3 million.
  • In the last 5 years, Merit Medical Systems' Accumulated Expenses soared by 5175.73% in 2021 and then tumbled by 2252.95% in 2022.
  • Quarter analysis of 5 years shows Merit Medical Systems' Accumulated Expenses stood at $159.0 million in 2021, then fell by 22.53% to $123.2 million in 2022, then fell by 2.23% to $120.4 million in 2023, then rose by 11.32% to $134.1 million in 2024, then rose by 9.92% to $147.4 million in 2025.
  • Its Accumulated Expenses stands at $147.4 million for Q3 2025, versus $140.2 million for Q2 2025 and $118.7 million for Q1 2025.